Skip to content
Grochi · Neutral pet information from South Korea · English edition한국어
Grochi.English edition
Labels & regulation

Human drugs and compounding at South Korean animal hospitals

Translated from the Korean edition · Editorial draft, not professionally reviewed. This page is an English translation of the Korean edition as checked on 2026-11-22. If the two differ, the Korean edition is the reference. 한국어판 (Korean edition)

Human drugs and compounding at South Korean animal hospitals
Short answer

South Korea's Pharmaceutical Affairs Act, Veterinarians Act and Rules on the Handling of Veterinary Drugs, etc. leave a route for animal hospitals to buy human prescription medicines for treatment but require records, while the U.S. FDA and the UK government tie use outside the authorization to the veterinarian's responsibility.

Key takeaways

  • Article 85, paragraph 4 of the Korean Pharmaceutical Affairs Act (약사법) provides that an animal hospital opener may buy medicines from a pharmacy opener for the purpose of treating animals, and requires the transaction status to be prepared and kept.
  • Article 22 of the Rules on the Handling of Veterinary Drugs, etc. (동물용 의약품등 취급규칙) requires an animal hospital opener who buys and uses human prescription medicines from a pharmacy opener to record them in the ledger of Form No. 16-2 (별지 제16호의2서식) and keep it for 1 year.
  • Article 12-2 of the Veterinarians Act (수의사법) allows a veterinarian who personally prescribes, compounds and administers a prescription veterinary drug to omit the prescription, but requires that content to be entered in the Veterinary Prescription Management System (수의사처방관리시스템).
  • The U.S. FDA allows extralabel use only under a veterinarian's lawful order and within a veterinarian-client-patient relationship, and states that an animal drug compounded from bulk drug substances is not an FDA-approved drug.
  • An owner can ask the veterinarian whether a prescribed medicine is authorized for animals, is a human medicine, or was compounded at the hospital, and it is a good idea to get the medicine's name, target of use, method of use and precautions in an explanation or in writing.

Is it allowed for an animal hospital to use human drugs? A short answer first

This article does not cover how an owner can use human medicines on their own. It explains only how the law and the system in South Korea treat the use of human medicines in treatment, and the direct compounding of medicines, on the side of veterinarians and animal hospitals. This article cannot decide which medicine suits which animal, and it deliberately gives no medicine names or doses.

To answer briefly: Korea's Pharmaceutical Affairs Act provides that an animal hospital opener may buy medicines from a pharmacy opener for the purpose of treating animals. The Rules on the Handling of Veterinary Drugs, etc. (hereafter the Handling Rules) then provide that when an animal hospital opener buys and uses human prescription medicines from a pharmacy, the opener must keep a ledger and retain it for 1 year. In other words, the system leaves a purchasing route by which human medicines can be used in animal treatment, and in exchange requires records and management. However, in the text of the National Law Information Center (law.go.kr), I did not confirm an article on how the use of human medicines is restricted when a medicine authorized for animals exists.

The United States and the United Kingdom have a similar structure. The U.S. FDA allows use that differs from the authorized label only under a veterinarian's lawful order, and the UK government sets out the so-called cascade principle, in which a veterinarian chooses another medicine step by step when no suitable authorized medicine exists. In the United States and the United Kingdom, this reads as a structure in which an authorized animal medicine comes first and other medicines are used exceptionally, under the veterinarian's judgment and responsibility. In the Korean articles, I did not confirm an article that directly sets such an order of priority.

The article proceeds as follows: first the articles confirmed in Korea's Pharmaceutical Affairs Act, Veterinarians Act and Handling Rules, then the provisions on compounding and prescriptions, the standards of the United States and the United Kingdom, what an owner can check, and common misunderstandings.

Why are human drugs sometimes used in animal treatment?

A human medicine is a medicine authorized after review of its safety and efficacy in people, and a veterinary drug is a medicine separately authorized for animals. Article 85, paragraph 1 of Korea's Pharmaceutical Affairs Act places medicines and similar items intended for use only on animals under the jurisdiction of the Minister of Agriculture, Food and Rural Affairs or the Minister of Oceans and Fisheries. Human medicines fall under the Ministry of Health and Welfare and the Ministry of Food and Drug Safety, while animal medicines fall under the Ministry of Agriculture, Food and Rural Affairs (MAFRA), which shows that the two systems are separate.

Even so, the U.S. FDA explains why human ingredients are sometimes used in animal treatment. The FDA's guidance for veterinarians explains that AMDUCA (the Animal Medicinal Drug Use Clarification Act of 1994) allows veterinarians to use approved drugs in ways not stated on the label. Use not on the label means use in a different animal species, for a disease not on the label, or with a different dose, frequency or route of administration. Using an approved human medicine in an animal is also handled within this framework.

The UK government's cascade guidance has the same intent. The UK government describes the cascade as a risk-based decision tree that allows a veterinarian to treat an animal when no suitable authorized product exists, and states that prescribing decisions must be made case by case. In the end, human medicines appear in animal treatment because medicines authorized for animals do not cover every species and every situation, and the system, instead of blocking this entirely, regulates who does it and under what conditions.

However, this is not a basis for an owner to give a human medicine. All of these systems assume a situation in which a veterinarian examines the animal and takes responsibility. The risks of an owner using human medicines directly are covered in a separate article.

In Korea: the scope of buying, selling and administering medicines at an animal hospital

Article 85, paragraph 4 of the Pharmaceutical Affairs Act provides that an animal hospital opener under the Veterinarians Act may sell veterinary drugs to animal keepers, and, for the purpose of treating animals, may buy medicines from a pharmacy opener under the proviso of Article 50, paragraph 2. In this case, the animal hospital opener must prepare and keep the transaction status as prescribed by an ordinance of the Ministry of Agriculture, Food and Rural Affairs. Article 50, paragraph 2 of the Pharmaceutical Affairs Act prohibits a pharmacy opener from selling prescription medicines other than when compounding under a prescription from a physician or dentist, but makes an exception for sales to an animal hospital opener under the Veterinarians Act as prescribed by an ordinance of the Ministry of Health and Welfare. Paragraph 3 of the same Article requires that when a pharmacy opener sells prescription medicines to an animal hospital opener, the animal hospital's name, contact details, the medicine name, quantity, date of sale and so on be submitted to the Drug Management Integrated Information Center (의약품관리종합정보센터).

Article 22, paragraph 1 of the Handling Rules requires two things of an animal hospital opener. One is to sell veterinary drugs only after performing an animal examination under the Veterinarians Act. The other is, when buying and using human prescription medicines from a pharmacy opener, to keep the human medicine ledger of Form No. 16-2 (별지 제16호의2서식), record the receipts and issues, and retain it for 1 year. The same paragraph also includes a compliance matter that medicines for which no manufacturing or import product approval has been obtained, or no product notification made, as veterinary drugs, etc. must not be sold or stored or displayed for sale. In the version of Article 22 marked as taking effect on January 1, 2027 (marked as amended on July 30, 2026), the wording on an animal hospital opener's 1-year retention of the ledger was written the same.

There are also sales records. Based on Article 85, paragraph 10 of the Pharmaceutical Affairs Act, Article 22, paragraph 3 of the Handling Rules requires an animal hospital opener who sells a veterinary drug falling under any subparagraph of Article 3-2, paragraph 1 to keep records of the date of sale, product name, quantity, use, purchaser and so on for at least 1 year. Those subparagraphs include veterinary hormone preparations, veterinary antibacterials (including antibiotics), veterinary anesthetics, and veterinary drugs containing narcotics.

The provisions on a veterinarian's prescriptions are in the Veterinarians Act. Article 12, paragraph 1 of the Veterinarians Act provides that a veterinarian may not issue a diagnosis certificate or prescription, or prescribe or administer a prescription veterinary drug under Article 85, paragraph 6 of the Pharmaceutical Affairs Act, without personally examining the animal or inspecting it. Article 13 requires a veterinarian to keep a medical record, write in it what was done in treatment and sign it, and says that the entries and retention period are set by an ordinance of the Ministry of Agriculture, Food and Rural Affairs. I did not confirm details such as the specific format for how a medicine's name is written in the medical record.

In Korea: compounding and prescriptions, and receiving medicines at a pharmacy

Article 23, paragraph 1 of the Pharmaceutical Affairs Act provides that no one other than a pharmacist or herb pharmacist may compound medicines. In contrast, Article 12-2, paragraph 3 of the Veterinarians Act provides that a veterinarian who personally prescribes, compounds and administers a prescription veterinary drug may choose not to issue a prescription, and in this case requires matters set by an ordinance of the Ministry of Agriculture, Food and Rural Affairs, such as the name, method of use and dose of the prescription veterinary drug, to be entered in the Veterinary Prescription Management System (수의사처방관리시스템). The addenda to the Pharmaceutical Affairs Act contain a transitional provision stating that a veterinarian may compound, personally, a veterinary drug that he or she uses for treatment, notwithstanding the amended provisions of Article 23, paragraphs 1 and 2. In the text at the National Law Information Center, this provision is found as Article 8 of the Addenda to Act No. 8365 (April 11, 2007). However, I did not confirm to what extent this provision is still in effect. Therefore, this article does not state definitively the current legal scope of what kinds of medicines a veterinarian may make, and by what method.

When a veterinarian issues a prescription, Article 12-2, paragraph 1 of the Veterinarians Act provides that a prescription is issued when a prescription veterinary drug needs to be administered, and paragraph 2 says it must be issued through the Veterinary Prescription Management System (수의사처방관리시스템). If there is an unavoidable reason set by Presidential decree, such as a computer system failure or a visit for treatment away from the clinic, it may be issued another way and then must be registered in the system within 3 days after the reason ends. Paragraph 5 requires the prescribing veterinarian to respond immediately to inquiries from the person who compounds and sells the medicine, with exceptions such as when the veterinarian is giving emergency treatment or is in the middle of surgery or a procedure.

A prescription veterinary drug is, under Article 85, paragraph 6 of the Pharmaceutical Affairs Act, a medicine that a wholesaler cannot sell without a veterinarian's prescription. Paragraph 7 says a pharmacy opener may sell such a medicine without a prescription, but excludes injectable antibiotic preparations and injectable biological preparations. An owner who receives a medicine at a pharmacy may also find it worth knowing that there are medicines for which the pharmacist must give the animal owner medication guidance. Article 3-2 of the Handling Rules requires a pharmacist at a veterinary pharmacy (동물약국) and the managing pharmacist of a wholesaler, when selling prescription veterinary drugs or hormone preparations, antibacterials, anesthetics and the like, to give the animal owner medication guidance, and to include in it the medicine's name, target of use, method and dose, efficacy and effects, side effects and contraindications, withdrawal period, storage method and expiry date. The person under this duty is the pharmacist, and it is not an article that directly sets an explanation duty for a veterinarian at an animal hospital. The article in the Veterinarians Act that sets explanation and written consent is Article 13-2, whose subject is major treatment such as surgery and blood transfusion, so its scope differs from an ordinary explanation of a medicine prescription.

How it differs from overseas standards: extralabel use and compounding in the United States

In its AMDUCA guidance, the U.S. FDA Center for Veterinary Medicine defines use that differs from the authorized label as extralabel use, and explains that it may be done only by a veterinarian, or on a veterinarian's lawful order, within a veterinarian-client-patient relationship (VCPR). It states that a layperson cannot do it unless under the supervision of a licensed veterinarian. It also says that without the relationship, the medicine may be unsafe and may become an adulterated drug. The FDA's resource for veterinarians explains that for a VCPR to exist, the veterinarian must take responsibility for medical judgments, know the animal well enough to make at least a preliminary diagnosis, and be available for follow-up in case of an adverse reaction or treatment failure.

The FDA explains that extralabel use is limited to situations in which the animal's health is threatened, and that use to enhance production is not permitted. Stricter conditions apply to food animals: if an approved animal drug exists for the same use, extralabel use of an approved human drug is not permitted. For companion animals, on the other hand, the FDA's resource for veterinarians notes that there are currently no approved drugs for which extralabel use is prohibited. Even so, the VCPR, clinical judgment and recordkeeping duties are summarized as applying to companion animals as well. It advises that the label must include the prescribing veterinarian's name and address, directions for use and so on, and that records must be kept for 2 years or for whatever other period federal or state law sets.

On compounding, the FDA states that an animal drug compounded from bulk drug substances is not an FDA-approved drug, and that the FDA has not reviewed its safety, effectiveness, manufacturing quality, or labeling and packaging. It says the law permits compounding that uses an approved finished drug as the source, while compounding from bulk drug substances is covered by a guidance document (GFI #256, issued on April 14, 2022). The FDA acknowledges that, when there is no appropriate approved drug and an approved drug cannot be used as the source, a drug compounded from bulk drug substances may be a medically necessary treatment, but points out that, unlike with approved drugs, the compounder has no duty to report adverse reactions and product defects to the FDA. The AMDUCA guidance separately states that the extralabel use rules do not permit compounding from active pharmaceutical ingredient (API) bulk substances.

How it differs from overseas standards: the cascade principle in the United Kingdom

The UK government (gov.uk) cascade guidance sets out the steps by which a veterinarian may prescribe an unauthorized medicine when no suitable authorized product exists. In this guidance, the order for Great Britain (GB) is as follows. First, an animal medicine authorized in Northern Ireland for that animal species and disease (a special import certificate is required); next, an animal medicine authorized in the UK for another species or another disease; after that, a human medicine authorized in the UK or an animal medicine authorized outside the UK; and last, an extemporaneous preparation made by a veterinarian, a pharmacist, or a person holding a manufacturing authorization. A human medicine is placed at the third step in this guidance.

The guidance states several conditions clearly. A veterinarian must first clinically assess the animal under his or her care, and only a veterinarian registered with the Royal College of Veterinary Surgeons (RCVS) may prescribe under the cascade. A veterinarian may not prescribe a human medicine only because it is cheaper, an imported medicine requires a special import certificate and doing without one is a breach. A veterinarian must obtain the animal owner's consent, and the record of consent must be kept for 5 years and shown on request. Even if someone else administers the medicine, the prescribing veterinarian is responsible for the choice and use of the medicine. For food-producing animals, the guidance also says the veterinarian must set the withdrawal period.

There are two noticeable differences from Korea. First, the United Kingdom states its step-by-step order in public guidance and expressly requires the owner's consent. The articles of the Pharmaceutical Affairs Act, Veterinarians Act and Handling Rules that I confirmed in Korea set management structures such as the route by which an animal hospital buys medicines, ledger records and the procedure for issuing prescriptions, but within the scope confirmed for this article, I did not find an article requiring the owner's consent when a human medicine is used. Second, the United States ties extralabel use to the VCPR and recordkeeping and distinguishes the approval status of compounded drugs. This comparison is limited to the scope of the documents confirmed, and does not judge which country's system is better.

What an owner can check

That a prescribed medicine has a human medicine ingredient or was compounded at the hospital does not in itself mean there is a problem. As seen above, the systems of Korea, the United States and the United Kingdom all recognize such use under the veterinarian's judgment and records. Even so, as the animal's owner, you can ask what medicine is being used and why. In Korea, if you receive a medicine at a pharmacy, you can also ask the pharmacist whether it is a medicine subject to medication guidance under the Handling Rules. The table below lists questions worth checking and is not guidance on which medicine to use.

  • Write down, or take a photo of, the medicine's name and ingredients, target of use and method of use.
  • Check what instructions you were given on what to do if you see a problem during administration.
  • Do not use leftover medicine on other animals or people, and ask the hospital how to dispose of it.
  • When you receive a medicine that needs a prescription at a pharmacy, get the pharmacist's explanation or a medication guide.
Questions you can ask a veterinarian or pharmacist about a prescribed medicine
What to askWhyBasis or reference
Is this medicine authorized for animals, or is it a human medicine?If the authorization category differs, the basis for use and the precautions may differPharmaceutical Affairs Act Article 85, paragraph 1 (animal medicines fall under MAFRA), Handling Rules Article 22 (ledger for human prescription medicines)
Is it a medicine the hospital made (compounded) itself?The U.S. FDA explains that a medicine compounded from bulk drug substances is not an approved drugFDA guidance on animal drug compounding, Veterinarians Act Article 12-2, paragraph 3
Why was this medicine chosen, and is there an authorized medicine that could replace it?The structure in which an authorized medicine comes first and other medicines are used at the veterinarian's judgmentUK government cascade guidance, FDA AMDUCA guidance
Did you get the target of use, method of use, side effects, withdrawal period and storage in writing or in an explanation?For some medicines, such as prescription veterinary drugs, the pharmacist has a duty to give medication guidance and the content to be included is setHandling Rules Article 3-2 (pharmacist's medication guidance)
If you got a prescription, where is the prescription recorded?Prescription veterinary drugs are managed through the prescription management systemVeterinarians Act Articles 12-2 and 12-3

Common misunderstandings

The first misunderstanding is the idea that, because the hospital uses human medicine ingredients, I may use human medicines at home. What the system recognizes is a veterinarian examining the animal and using the medicine on the basis of that judgment. The UK government says that under the cascade only a veterinarian may prescribe, and the U.S. FDA also says that a layperson cannot engage in extralabel use unless under the supervision of a licensed veterinarian.

The second misunderstanding is the two extremes that compounded medicines are all illegal or all safe. The FDA says that an animal drug compounded from bulk drug substances is an unapproved drug, while acknowledging that it may be a medically necessary treatment when no approved drug exists. In Korean law, Article 12-2, paragraph 3 of the Veterinarians Act contains a provision premised on a veterinarian's direct compounding, but I did not confirm the specific scope of compounding. So this article does not state definitively that compounded medicines are legal or illegal.

The third misunderstanding is the idea that an animal hospital selling medicines is the same as an ordinary pharmacy sale. Article 22 of the Handling Rules provides that an animal hospital opener sells veterinary drugs after performing an animal examination, and that they must not be sold or displayed anywhere other than the place of sale. Examination comes first in this structure.

The fourth misunderstanding is the idea that human medicines are always cheaper, so the hospital should do it that way. The UK government advises that a human medicine must not be prescribed only because it is cheaper. I did not confirm a corresponding article in Korea, so if cost is a concern, it is practical to ask the hospital about the price of the medicine and the alternatives first.

The fifth misunderstanding is the idea that leftover medicine can be saved and used next time. The FDA requires the label of a medicine compounded or prescribed for extralabel use to carry the prescribing veterinarian's name and address and directions for use, but this article did not confirm an explanation of reusing leftover medicine. Ask the hospital how to dispose of leftover medicine.

When to contact a veterinarian, pharmacist or local government

In the following cases, it is a good idea not to stop at this article and to ask a professional directly.

  • If, after giving a medicine, vomiting, diarrhea, lethargy, trembling or what looks like difficulty breathing appears, contact an animal hospital right away, and if the signs are severe, the animal seems to have trouble breathing, or it collapses, go to a hospital that can provide emergency care.
  • When you are not sure whether a prescribed medicine is for animals or for people, or whether it is compounded, ask the prescribing veterinarian or the pharmacist who compounded it.
  • If you did not receive the medicine's instructions or medication guidance, ask the hospital or pharmacy for it.
  • If you doubt whether an animal hospital's sale or compounding of medicines complies with the law, ask the relevant local government department or the Animal and Plant Quarantine Agency (APQA). This article does not judge whether an individual case is lawful.
  • For a dispute over medicine prices or treatment fees, a separate consultation body is the right place to ask.

Finally, this article is an editorial draft that organizes the articles confirmed by opening the text of the National Law Information Center as of November 22, 2026, together with FDA and UK government guidance. Laws and notices can change, and amendments with different effective dates are scheduled for some articles, so the current articles must be checked directly at the National Law Information Center.

Frequently asked questions

Q Is it lawful for an animal hospital to use ingredients of medicines that people take?

Article 85, paragraph 4 of the Pharmaceutical Affairs Act provides that an animal hospital opener may buy medicines from a pharmacy opener for the purpose of treating animals, and Article 22 of the Handling Rules provides that when human prescription medicines are bought and used, the ledger must be kept for 1 year. This article does not judge whether the use of an individual medicine is lawful.

Q If a medicine authorized for animals exists, must only that medicine be used?

An article setting such a restriction was not confirmed in the text of Korean law. The U.S. FDA explains extralabel use as applying, among other cases, when no approved drug exists, and the UK government sets out steps used when no authorized product exists. It is a good idea to ask a veterinarian which medicine is suitable.

Q May a veterinarian compound a medicine personally?

Article 12-2, paragraph 3 of the Veterinarians Act provides that a veterinarian who personally prescribes, compounds and administers a prescription veterinary drug may omit the prescription, and in this case requires the content to be entered in the system. However, this article did not confirm the specific scope of compounding.

Q Is a compounded medicine an FDA-approved drug?

The FDA states that an animal drug compounded from bulk drug substances is not an FDA-approved drug, and that, unlike with approved drugs, the compounder has no duty to report adverse reactions. It also advises that it may be a medically necessary treatment when no approved drug exists.

Q Can I get an explanation when receiving an animal medicine at a pharmacy?

Article 3-2 of the Handling Rules requires a pharmacist at a veterinary pharmacy and the managing pharmacist of a wholesaler, when selling prescription veterinary drugs and the like, to give the animal owner medication guidance, orally or in a written medication guide, and to include the medicine's name, target of use, method and dose, side effects and so on.

Q What is the cascade in the United Kingdom?

It is a decision framework explained in UK government guidance that lets a veterinarian choose another medicine step by step when no suitable authorized product exists. The guidance says the veterinarian must first clinically assess the animal and obtain the owner's consent, and that a human medicine may not be prescribed only because it is cheaper.

Q May I use a medicine received at the hospital on another animal at home?

It is not advised. The systems of Korea, the United States and the United Kingdom all assume a veterinarian's examination and judgment, and the FDA explains that the label of a medicine for extralabel use must carry the prescribing veterinarian's name and directions for use. Ask the hospital how to dispose of leftover medicine.

Limits and scope of this guide

This article is an editorial draft that has not had specialist veterinary or pharmacist review. It is not an article that decides the choice or dose of a medicine for an individual pet, and it does not cover how an owner can use human medicines. I could not confirm a Korean article restricting the use of human medicines when a medicine authorized for animals exists, the current specific scope of a veterinarian's compounding, or an article on a duty to explain to and obtain consent from the owner when prescribing a medicine. I could not open and check the easy-to-find living law information pages or the original PDF of the FDA's compounding guidance. Laws can be amended, so the current articles must be checked.

Translated from the Korean edition · Editorial draft, not professionally reviewed. The Korean edition is an explainer newly written from public sources; it is not a full translation of those sources. Veterinary expert review has not been completed. For decisions about your pet's health, talk to a veterinarian who knows your pet.

Sources and check dates

  1. Pharmaceutical Affairs Act (Articles 23, 50, 85, etc.) (약사법) ↗

    Used to confirm Article 85 on special rules for veterinary drugs (jurisdiction, an animal hospital opener's purchase and sale and retention of transaction status, sale of prescription veterinary drugs), Article 50, paragraphs 2 and 3, Article 23, paragraph 1, and the transitional provision on veterinarians' compounding (Article 8 of the Addenda to Act No. 8365).

  2. Veterinarians Act (Articles 12, 12-2, 12-3, 13 and 13-2) (수의사법) ↗

    Used to confirm the articles on a veterinarian's duty to examine personally, issuing prescriptions and the prescription management system, the duty to enter content when personally prescribing, compounding and administering, medical records, and explanation for major treatment such as surgery.

  3. Rules on the Handling of Veterinary Drugs, etc. (Articles 3-2 and 22) (동물용 의약품등 취급규칙) ↗

    Used to confirm the content of a pharmacist's medication guidance, the 1-year retention of an animal hospital opener's ledger of human prescription medicines, and the provision on retaining sales records.

  4. Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA) ↗

    Used as the basis for the definition of extralabel use, the conditions of a veterinarian's order and the VCPR, label statements, conditions for food animals, and the guidance on compounding and bulk drug substances.

  5. The Ins and Outs of Extra-Label Drug Use in Animals: A Resource for Veterinarians ↗

    Used as the basis for the VCPR requirements, label statements, 2-year recordkeeping, extralabel use of human drugs, and the explanation that there are no approved drugs prohibited for extralabel use in companion animals.

  6. Animal Drug Compounding ↗

    Used as the basis for the statement that an animal drug compounded from bulk drug substances is not approved, GFI #256 (2022-04-14), and the absence of a duty for the compounder to report adverse reactions.

  7. The cascade: prescribing unauthorised medicines ↗

    Used as the basis for the order of the GB cascade steps, clinical assessment, owner consent and 5-year record retention, and the guidance that a human medicine may not be prescribed only because of cost.

Korean edition checked · translated · each source may have a different check date. No paid partnerships.

This guide relies on 3 Korean laws or notices. Current effective dates and upcoming amendments are listed on Korean law check status. This is not legal advice.